Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W22 free peer-to-peer lending platform with 50K+ users and $20M+ annual loans; $2.5M from YC/Pioneer/Paul Graham creating legally binding loan docs for friends/family competing with Zirtue for personal lending formalization.
Pigeon is a United States-based peer-to-peer lending platform — backed by Y Combinator (W22) with $2.5 million in seed funding in May 2022 from Y Combinator, Pioneer Fund, and Paul Graham — providing individuals with a free platform for creating legally binding loan agreements with friends and family, formalizing the personal loans that people make to each other informally with proper documentation, payment schedules, and digital signatures that protect both lender and borrower relationships. Reaching 50,000+ users facilitating over $20 million in annual loan volume, Pigeon serves the large population of people who lend money to people they know but want the structure and accountability of a formal agreement without the cost of an attorney.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.